Resultados: 22

Net benefit of closure of patent forame oval in reduction of stroke rates: update meta analisys with randomized controlled trial and observational cohorts with propensity score matched studies

Int. j. cardiovasc. sci. (Impr.); 37 (suppl. 13), 2024
BACKGROUND: Cryptogenic strokes, accounting for 40% of acute ischemic strokes, are linked to patent foramen ovale (PFO). Despite research efforts, uncertainties remain about optimal prevention strategies. OBJECTIVES: Therefore, we aimed to review RCTs and Propensity Score Matching (PSM) Studies comparing...

Atorvastatin therapy for prevention of anthracycline-induced cardiotoxicity in cancer patients: a meta-analysis

Circulation; 150 (Suppl. 1), 2024
INTRODUCTION: Cancer therapy-induced cardiac dysfunction is a significant adverse effect of chemotherapeutic agents, particularly anthracyclines (ANT). High-potency statin therapy, such as atorvastatin, appears to exert a protective effect against this condition. OBJECTIVE: We aimed to perform a meta-ana...

Catheter ablation approach and outcome in HIV+ patients with atrial fibrillation: a systematic review and meta-analysis

Circulation; 150 (Suppl. 1), 2024
BACKGROUND: Catheter ablation has emerged as an effective treatment option for atrial fibrillation (AF) in the general population. However, limited data exist on the outcomes of catheter ablation in patients infected with the Human Immunodeficiency Virus (HIV+) with concomitant AF. OBJECTIVES: This syste...

Hybrid epicardial and endocardial ablation versus endocardial ablation in patients with persistent and longstanding persistent atrial fibrillation: an updated systematic review and meta-analysis

Circulation; 150 (Suppl. 1), 2024
BACKGROUND: Some studies suggest a potential benefit of hybrid ablation for patients with persistent and long-standing persistent atrial fibrillation (AF), but its efficacy and safety remain debated. OBJECTIVE: We conducted a systematic review and meta-analysis to compare the efficacy and safety of hybri...

DOACs versus aspirin for secondary prevention of stroke after ESUS: an updated systematic review and meta-analysis of randomized clinical trials

Circulation; 150 (Suppl. 1), 2024
BACKGROUND: Embolic stroke of undetermined source (ESUS) is a nonlacunar ischemic stroke with no clear cause, having a 4%-5% annual recurrence rate. The potential benefits of direct oral anticoagulants (DOACs) relative to aspirin in patients with ESUS remain unclear. OBJECTIVE: We aimed to perform a syst...

Bevacizumab-induced hypertension in patients with glioblastoma: a systematic review and meta-analysis

Eur. heart j; 45 (Suppl. 1), 2024
BACKGROUND: Bevacizumab is a monoclonal antibody medication used as standard treatment for different types of cancers, one of them is glioblastoma, which is the most common primary brain tumor. PURPOSE: We aimed to assess bevacizumab and its effects on inducing hypertension in patients with glioblastoma....

Efficacy and safety of leadless pacemaker implantation post transcatheter aortic valve replacement: asystematic review and single-arm meta-analysis

Int. j. cardiovasc. sci. (Impr.); 37 (suppl.9), 2024
BACKGROUND: The leadless pacemaker has emerged as a promising alternative for patients requiring artificial cardiac stimulation. Advanced atrioventricular block (AVB) is the primary indication for leadless pacemaker (LP) implantation in patients who have undergone transcatheter aortic valve replacement (...

Epicardial substrate ablation in high-risk brugada syndrome patients: systematic review and single-arm meta-analysis

Int. j. cardiovasc. sci. (Impr.); 37 (suppl.9), 2024
INTRODUCTION: Brugada syndrome (BrS) is a genetic heart disease that predisposes individuals to malignant ventricular arrhythmias and sudden cardiac death (SCD). Although implantable cardioverter-defibrillators (ICDs) and quinidine are primary treatments, recurrent BrS-triggered cardiac ventricular arrhy...

Segurança e eficácia da ablação de altíssima potência e curta duração versus a ablação de alta potência e curta duração em pacientes com fibrilação atrial: uma revisão sistemática e meta-análise atualizada
Safety and efficacy of very high-power short-duration ablation versus high-power short-duration ablation in patients with atrial fibrillation: an updated systematic review and meta-analysis

Arq. bras. cardiol; 121 (9 supl.1), 2024
INTRODUÇÃO: A ablação da fibrilação atrial (FA) é essencialmente baseada no isolamento das veias pulmonares (PVI), no entanto, a recorrência da FA devido à reconexão da VP é um desafio. O uso da técnica de alta potência de curta duração (HPSD; > 40 W) mostrou-se mais eficaz e seguro, propo...

The decreased left ventricular ejection fraction in patients using trastuzumab deruxtecan for her2-positive breast cancer: a systematic review and meta-analysis

Arq. bras. cardiol; 121 (9 supl.1), 2024
Breast Cancer (BC) is one of the most common cancers diagnosed in population femmale and it has several subtypes, one of them being theexpressing human epidermal growth factor receptor 2 positive (HER2 +), one of the treatments for HER2+ breast cancer consists of chemotherapy plus trastuzumab deruxtecan....